NCT03784469 is a NA clinical trial of Changing body position in bed in Liver Cancer, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT03784469?

NCT03784469 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT03784469?

Interventions in NCT03784469: Changing body position in bed.

What condition does NCT03784469 study?

NCT03784469 studies Liver Cancer, Transcatheter Arterial Chemoembolization.

Is NCT03784469 still recruiting?

NCT03784469 is currently completed. Last updated 21 October 2019.

Last reviewed 2019-10-21 · How we verify

NCT03784469

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC

Completed NA Last updated 21 October 2019

What this trial tests

NA trial testing Changing body position in bed in Liver Cancer in 80 participants. Completed in 28 August 2018.

Timeline

21 February 2018

Primary endpoint
28 August 2018

28 August 2018

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	80
Start date	21 February 2018
Primary completion	28 August 2018
Estimated completion	28 August 2018
Sites	1 location across Taiwan

Drugs / interventions tested

Changing body position in bed

Conditions studied

Liver Cancer — all drugs for Liver Cancer →
Transcatheter Arterial Chemoembolization — all drugs for Transcatheter Arterial Chemoembolization →

Sponsor

National Taiwan University Hospital

Who can join

18 and older, any sex, with Liver Cancer or Transcatheter Arterial Chemoembolization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Changing patients' position in the bed after TACE can decrease the level of back pain without increasing the amount of bleeding and hematoma,bring patients some comfort and relieving abdominal bloating, increase patients' satisfaction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects and safety of body positioning on back pain after transcatheter arterial chemoembolization in people with hepatocellular carcinoma: A randomized controlled study.
Chang KT, Liu CJ, Tsai HT, Hsu TP, et al · · 2020 · cited 4× · PMID 32535341 · DOI 10.1016/j.ijnurstu.2020.103641

Verify or expand the search:

Other recruiting trials for Liver Cancer

Currently open trials in the same condition.

NCT07295275 — Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection · recruiting
NCT07410494 — Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07295340 — Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection · recruiting
NCT07504367 — Large Language Models Assist in Tumor MDT · NA · recruiting
NCT07447050 — Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · Phase 2 · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03784469 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 21 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing